ERNA   $0.214  2.05% Market Closed After Close 0.2136 -0.19%

Ernexa Therapeutics Inc.
Total Cash 2.59M
totalCashPerShare 0.478
EBITDA -21.86M
Total Debt 49.20M
quickRatio 0.293
currentRatio 0.373
Total Revenue 162.00K
debtToEquity
Revenue/Share 0.03
ROA -0.29415
ROE
grossProfits
freeCashflow -11.78M
operatingCashflow -16.49M
earningsGrowth
revenueGrowth
grossMargins -1.11111
ebitdaMargins 0.0
operatingMargins -104.914894
profitMargins 0.0
enterpriseValue 52.52M
forwardPE
floatShares 3.28M
sharesOutstanding 5.41M
sharesShort 61.00K
sharesShortPriorMonth 36.60K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.39%
heldPercentInstitutions 0.07%
Short Ratio help_outline 1.03%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -1.576
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -23.94M
trailingEps -4.43%
forwardEps -9.60%
enterpriseToEbitda -2.40
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2022
institutionsCount 21
lastUpdated Nov. 2, 2024, 2:08 a.m.